Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells.

PubWeight™: 1.58‹?› | Rank: Top 4%

🔗 View Article (PMID 7541307)

Published in Immunity on January 01, 1995

Authors

I Correa1, D H Raulet

Author Affiliations

1: Department of Molecular and Cell Biology, University of California, Berkeley 94720, USA.

Articles citing this

Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 3.38

Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med (1996) 2.60

Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med (1998) 2.57

The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med (1997) 1.91

A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J Exp Med (1996) 1.50

Cis interactions of immunoreceptors with MHC and non-MHC ligands. Nat Rev Immunol (2008) 1.50

A reassessment of the role of B7-1 expression in tumor rejection. J Exp Med (1995) 1.44

Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J Virol (1995) 1.40

Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc Natl Acad Sci U S A (1997) 1.29

Self and viral peptides can initiate lysis by autologous natural killer cells. Proc Natl Acad Sci U S A (1997) 1.29

Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J Exp Med (1999) 1.27

Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J Exp Med (2000) 1.23

Control of natural killer cell-mediated innate resistance against the intracellular pathogen Listeria monocytogenes by gamma/delta T lymphocytes. Infect Immun (1996) 1.17

The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand. J Exp Med (2001) 1.17

Natural killer cell receptors specific for major histocompatibility complex class I molecules. Proc Natl Acad Sci U S A (1995) 1.16

The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand. Proc Natl Acad Sci U S A (1996) 1.15

Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med (1997) 1.13

Innate immune control of HIV. Cold Spring Harb Perspect Med (2012) 1.09

Using a baculovirus display library to identify MHC class I mimotopes. Proc Natl Acad Sci U S A (2005) 1.07

The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis. J Exp Med (1999) 1.05

Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor. J Exp Med (1999) 0.98

Distinct MHC class I-dependent NK cell-activating receptors control cytomegalovirus infection in different mouse strains. J Exp Med (2011) 0.98

Activating Ly-49D and inhibitory Ly-49A natural killer cell receptors demonstrate distinct requirements for interaction with H2-D(d). J Exp Med (2000) 0.93

Hybrid resistance and the Ly-49 family of natural killer cell receptors. J Exp Med (1995) 0.91

Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease. J Clin Invest (1996) 0.88

Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands. J Immunol (2011) 0.88

Stress signals activate natural killer cells. J Exp Med (2002) 0.86

Neurons preferentially respond to self-MHC class I allele products regardless of peptide presented. J Immunol (2009) 0.86

Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis. Proc Natl Acad Sci U S A (1998) 0.84

The virus-specific and allospecific cytotoxic T-lymphocyte response to lymphocytic choriomeningitis virus is modified in a subpopulation of CD8(+) T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2. J Virol (2000) 0.84

Identification of murine H2-Dd- and H2-Ab-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis. Infect Immun (2004) 0.82

HLA class I specificity for natural killer cell receptor CD94/NKG2A: two for one in more ways than one. Proc Natl Acad Sci U S A (1998) 0.81

Localization of CD8 T cell epitope within cardiac myosin heavy chain-α334-352 that induces autoimmune myocarditis in A/J mice. Int J Cardiol (2015) 0.78

Recognition of class I MHC by a rat Ly49 NK cell receptor is dependent on the identity of the P2 anchor amino acid of bound peptide. J Immunol (2011) 0.76

Articles by these authors

Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature (1990) 8.57

Properties and applications of monoclonal antibodies directed against determinants of they Thy-1 locus. J Immunol (1979) 7.79

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (1992) 7.15

Developmental potential and dynamic behavior of hematopoietic stem cells. Cell (1986) 5.98

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol (2000) 5.45

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature (2001) 4.93

Developmental regulation of T-cell receptor gene expression. Nature (1985) 4.53

B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc Natl Acad Sci U S A (1987) 3.33

Viral infections induce abundant numbers of senescent CD8 T cells. J Immunol (2001) 3.04

Diversity, rearrangement, and expression of murine T cell gamma genes. Cell (1986) 2.81

Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med (1998) 2.57

The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell (1997) 2.34

Positive selection determines T cell receptor V beta 14 gene usage by CD8+ T cells. J Exp Med (1989) 2.22

Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity (1999) 2.18

Fractionation of lymphocyte populations with monoclonal antibodies specific for LYT-2.2 and LYT-3.1. J Immunol (1980) 1.86

Class I dependence of the development of CD4+ CD8- NK1.1+ thymocytes. J Exp Med (1994) 1.84

Expression and function of interleukin-2 receptors on immature thymocytes. Nature (1985) 1.82

Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen. J Exp Med (1982) 1.76

NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. J Immunol (2000) 1.72

Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. Nature (1995) 1.71

Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur J Immunol (1996) 1.67

Immunology. Antigens for gamma/delta T cells. Nature (1989) 1.65

Acquisition of Ly49 receptor expression by developing natural killer cells. J Exp Med (1998) 1.60

The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice. J Immunol (1997) 1.58

A differentiation factor required for the expression of cytotoxic T-cell function. Nature (1982) 1.56

T-cell receptor variable region gene usage in T-cell populations. Proc Natl Acad Sci U S A (1986) 1.56

Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proc Natl Acad Sci U S A (1990) 1.49

Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J Exp Med (1999) 1.45

Selection is not required to produce invariant T-cell receptor gamma-gene junctional sequences. Nature (1993) 1.45

Ordered rearrangement of variable region genes of the T cell receptor gamma locus correlates with transcription of the unrearranged genes. J Exp Med (1993) 1.36

Strategies for target cell recognition by natural killer cells. Immunol Rev (2001) 1.31

Identification of a T-cell-specific transcriptional enhancer located 3' of C gamma 1 in the murine T-cell receptor gamma locus. Proc Natl Acad Sci U S A (1991) 1.30

Characterization of a novel murine T cell-activating factor. J Immunol (1987) 1.29

Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur J Immunol (2000) 1.27

Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur J Immunol (1997) 1.27

Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J Exp Med (2000) 1.23

NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. Eur J Immunol (2000) 1.21

Expression and function of NK cell receptors in CD8+ T cells. Curr Opin Immunol (2001) 1.20

Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J Immunol (1997) 1.19

Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J Exp Med (1996) 1.18

Evidence that gammadelta versus alphabeta T cell fate determination is initiated independently of T cell receptor signaling. J Exp Med (2001) 1.18

T-cell lineages, repertoire selection and tolerance induction. Immunol Rev (1988) 1.17

CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J Exp Med (1993) 1.16

Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity (2000) 1.15

Immunology. A sense of something missing. Nature (1992) 1.13

MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. Eur J Immunol (2001) 1.12

2F1 antigen, the mouse homolog of the rat "mast cell function-associated antigen", is a lectin-like type II transmembrane receptor expressed by natural killer cells. Eur J Immunol (1998) 1.09

Predominant variable region gene usage by gamma/delta T cell receptor-bearing cells in the adult thymus. J Exp Med (1988) 1.09

The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-gamma and -delta gene expression. J Immunol (1993) 1.08

Expression of the V beta 5.1 gene by murine peripheral T cells is controlled by MHC genes and skewed to the CD8+ subset. J Immunol (1990) 1.07

Events that regulate differentiation of alpha beta TCR+ and gamma delta TCR+ T cells from a common precursor. Semin Immunol (1997) 1.06

Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. J Immunol (1999) 1.05

The developmental fate of T cells is critically influenced by TCRgammadelta expression. Immunity (1998) 1.04

IL-6 and IL-1 synergize to stimulate IL-2 production and proliferation of peripheral T cells. J Immunol (1989) 1.03

Defective development of gamma/delta T cells in interleukin 7 receptor-deficient mice is due to impaired expression of T cell receptor gamma genes. J Exp Med (1999) 1.02

The immunobiology of gamma delta+ T cells. Semin Immunol (1990) 1.00

Developmentally programmed rearrangement of T cell receptor Vgamma genes is controlled by sequences immediately upstream of the Vgamma genes. Immunity (1998) 1.00

Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells. Proc Natl Acad Sci U S A (1999) 0.97

Natural killer cells: stress out, turn on, tune in. Curr Biol (1999) 0.97

Major histocompatibility complex genes determine natural killer cell tolerance. Eur J Immunol (1996) 0.96

Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J Exp Med (1997) 0.96

The role of short homology repeats and TdT in generation of the invariant gamma delta antigen receptor repertoire in the fetal thymus. Immunity (1995) 0.96

Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic. Eur J Immunol (1997) 0.96

Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors. J Immunol (2001) 0.96

Rearrangement by inversion of a T-cell receptor delta variable region gene located 3' of the delta constant region gene. Proc Natl Acad Sci U S A (1989) 0.93

The role of c-Myb or a related factor in regulating the T cell receptor gamma gene enhancer. J Immunol (1995) 0.92

T cells produce TRF in response to Con A and factors in T cell hybridoma supernatants. J Immunol (1982) 0.91

Evidence that productive rearrangements of TCR gamma genes influence the commitment of progenitor cells to differentiate into alpha beta or gamma delta T cells. Eur J Immunol (1995) 0.91

Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody. J Immunol (1994) 0.90

Toward a quantitative analysis of the repertoire of class I MHC-specific inhibitory receptors on natural killer cells. Curr Top Microbiol Immunol (1998) 0.90

Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Eur J Immunol (1994) 0.89

A novel element upstream of the Vgamma2 gene in the murine T cell receptor gamma locus cooperates with the 3' enhancer to act as a locus control region. J Exp Med (1999) 0.86

Helper T cells for cytotoxic T lymphocytes need not be I region restricted. J Exp Med (1982) 0.84

T cell receptor gamma gene regulatory sequences prevent the function of a novel TCRgamma/pTalpha pre-T cell receptor. Immunity (1998) 0.83

Expression of the Mls-1a superantigen results in an increased frequency of V beta 14+ T cells. J Immunol (1992) 0.82

Selective expression of V delta 6 genes by B2A2- CD4- CD8- T cell receptor gamma/delta thymocytes. Eur J Immunol (1990) 0.81

Tolerance, and more. Cell (1987) 0.78

A new monoclonal antibody reactive with several Ly49 NK cell receptors mediates redirected lysis of target cells. Hybridoma (1999) 0.78

A phosphorylated, disulfide-linked membrane protein in murine cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1986) 0.78

A novel gamma delta T cell receptor for antigen adds limited diversity to the gamma delta repertoire in adult thymus. J Immunol (1989) 0.77

Does a low level of expression of HLA molecules engender autoimmunity? N Engl J Med (1999) 0.75

Generation of short-term murine natural killer cell clones to analyze Ly49 gene expression. Methods Mol Biol (2000) 0.75

T cell gamma receptor. Immunol Res (1987) 0.75